Is nonnephrotoxic immunosuppression a possibility?
L
L
Bäckman
J M
JM
Morales
D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects* / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000139:chemically induced*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000627:therapeutic use; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus